Charles H. Li

10.6k total citations · 5 hit papers
21 papers, 4.5k citations indexed

About

Charles H. Li is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Charles H. Li has authored 21 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 8 papers in Genetics and 3 papers in Cancer Research. Recurrent topics in Charles H. Li's work include Genomics and Chromatin Dynamics (11 papers), Epigenetics and DNA Methylation (3 papers) and Protein Degradation and Inhibitors (3 papers). Charles H. Li is often cited by papers focused on Genomics and Chromatin Dynamics (11 papers), Epigenetics and DNA Methylation (3 papers) and Protein Degradation and Inhibitors (3 papers). Charles H. Li collaborates with scholars based in United States, United Kingdom and China. Charles H. Li's co-authors include Richard A. Young, Ibrahim I. Cissé, Won‐Ki Cho, Choongman Lee, Jan-Hendrik Spille, Rudolf Jaenisch, Tong Ihn Lee, Alicia V. Zamudio, Nancy M. Hannett and Denes Hnisz and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Charles H. Li

21 papers receiving 4.5k citations

Hit Papers

Transcription Factors Activate Genes through the Phase-Se... 2016 2026 2019 2022 2018 2018 2016 2017 2018 400 800 1.2k

Peers

Charles H. Li
Alicia V. Zamudio United States
Beth Martin United States
Alon Goren United States
Peggy S. Eis United States
Gary LeRoy United States
Reza Kalhor United States
C. Anthony Blau United States
Alicia V. Zamudio United States
Charles H. Li
Citations per year, relative to Charles H. Li Charles H. Li (= 1×) peers Alicia V. Zamudio

Countries citing papers authored by Charles H. Li

Since Specialization
Citations

This map shows the geographic impact of Charles H. Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles H. Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles H. Li more than expected).

Fields of papers citing papers by Charles H. Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles H. Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles H. Li. The network helps show where Charles H. Li may publish in the future.

Co-authorship network of co-authors of Charles H. Li

This figure shows the co-authorship network connecting the top 25 collaborators of Charles H. Li. A scholar is included among the top collaborators of Charles H. Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles H. Li. Charles H. Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xie, Bing, Chuanyun Xu, Jacqueline Niu, et al.. (2023). Multiplex epigenome editing of MECP2 to rescue Rett syndrome neurons. Science Translational Medicine. 15(679). eadd4666–eadd4666. 49 indexed citations
2.
Neumayr, Christoph, Vanja Haberle, Leonid Serebreni, et al.. (2022). Differential cofactor dependencies define distinct types of human enhancers. Nature. 606(7913). 406–413. 55 indexed citations
3.
Wang, Yao, et al.. (2022). The Origin and Evolution of Bladder Cancer Stem Cells. Frontiers in Cell and Developmental Biology. 10. 950241–950241. 8 indexed citations
4.
Pomplun, Sebastian, Muhammad Jbara, Carly K. Schissel, et al.. (2021). Parallel Automated Flow Synthesis of Covalent Protein Complexes That Can Inhibit MYC-Driven Transcription. ACS Central Science. 7(8). 1408–1418. 26 indexed citations
5.
Li, Charles H., Eliot L. Coffey, Alessandra Dall’Agnese, et al.. (2020). MeCP2 links heterochromatin condensates and neurodevelopmental disease. Nature. 586(7829). 440–444. 146 indexed citations
6.
Cho, Won‐Ki, et al.. (2018). Mediator and RNA polymerase II clusters associate in transcription-dependent condensates. Science. 361(6400). 412–415. 948 indexed citations breakdown →
7.
Boija, Ann, Isaac A. Klein, Benjamin R. Sabari, et al.. (2018). Transcription Factors Activate Genes through the Phase-Separation Capacity of Their Activation Domains. Cell. 175(7). 1842–1855.e16. 1200 indexed citations breakdown →
8.
Liu, X. Shawn, Hao Wu, Marine Krzisch, et al.. (2018). Rescue of Fragile X Syndrome Neurons by DNA Methylation Editing of the FMR1 Gene. Cell. 172(5). 979–992.e6. 335 indexed citations breakdown →
9.
Abraham, Brian J., Denes Hnisz, Abraham S. Weintraub, et al.. (2017). Small genomic insertions form enhancers that misregulate oncogenes. Nature Communications. 8(1). 14385–14385. 62 indexed citations
10.
Weintraub, Abraham S., Charles H. Li, Alicia V. Zamudio, et al.. (2017). YY1 Is a Structural Regulator of Enhancer-Promoter Loops. Cell. 171(7). 1573–1588.e28. 661 indexed citations breakdown →
11.
Hnisz, Denes, Abraham S. Weintraub, Daniel S. Day, et al.. (2016). Activation of proto-oncogenes by disruption of chromosome neighborhoods. Science. 351(6280). 1454–1458. 679 indexed citations breakdown →
12.
Josefowicz, Steven Z., Miho Shimada, Charles H. Li, et al.. (2016). Chromatin Kinases Act on Transcription Factors and Histone Tails in Regulation of Inducible Transcription. Molecular Cell. 64(2). 347–361. 53 indexed citations
13.
Jiang, Tingting, Weiwei Shi, Vikram B. Wali, et al.. (2016). Predictors of Chemosensitivity in Triple Negative Breast Cancer: An Integrated Genomic Analysis. PLoS Medicine. 13(12). e1002193–e1002193. 57 indexed citations
14.
Josefowicz, Steven Z., Miho Shimada, Charles H. Li, et al.. (2016). Targeting chromatin kinases reveals their role in inducible transcription of inflammatory genes. The Journal of Immunology. 196(1_Supplement). 202.13–202.13. 1 indexed citations
15.
Li, Charles H., et al.. (2015). Hydroxychloroquine-induced agranulocytosis in a patient with long-term rheumatoid arthritis. European Journal of Rheumatology. 3(2). 91–92. 17 indexed citations
16.
Noh, Kyung‐Min, Haibo Wang, Hyunjae R. Kim, et al.. (2015). Engineering of a Histone-Recognition Domain in Dnmt3a Alters the Epigenetic Landscape and Phenotypic Features of Mouse ESCs. Molecular Cell. 59(1). 89–103. 68 indexed citations
17.
Li, Charles H., et al.. (2012). Targeting Cancer Gene Therapy with Magnetic Nanoparticles. Oncotarget. 3(4). 365–370. 42 indexed citations
18.
Salomonsson, Stina, Cecilia Grundtman, Shi‐Jin Zhang, et al.. (2009). Upregulation of MHC class I in transgenic mice results in reduced force‐generating capacity in slow‐twitch muscle. Muscle & Nerve. 39(5). 674–682. 22 indexed citations
19.
Kuruvilla, John, Heather A. Leitch, Linda M. Vickars, et al.. (2003). Aplastic anemia following administration of a tumor necrosis factor‐α inhibitor. European Journal Of Haematology. 71(5). 396–398. 43 indexed citations
20.
Li, Charles H. & Stephen Wiggins. (1997). Invariant Manifolds and Fibrations for Perturbed Nonlinear Schrödinger Equations. Applied mathematical sciences. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026